Plante Moran Financial Advisors, LLC Crispr Therapeutics Ag Transaction History

Plante Moran Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$60.67 - $89.12 $2,366 - $3,475	39 New	39 $2,000
Q3 2020 Nov 12, 2020	SELL	$78.5 - $100.64 $86,350 - $110,704	-1,100 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$38.5 - $76.05 $42,350 - $83,655	1,100 New	1,100 $81,000
Q1 2020 May 07, 2020	SELL	$33.68 - $62.53 $170,084 - $315,776	-5,050 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $185,234 - $369,306	5,050 New	5,050 $308,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.